Does REVUMENIB Cause Product use issue? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Product use issue have been filed in association with REVUMENIB (Revuforj). This represents 3.5% of all adverse event reports for REVUMENIB.
13
Reports of Product use issue with REVUMENIB
3.5%
of all REVUMENIB reports
1
Deaths
1
Hospitalizations
How Dangerous Is Product use issue From REVUMENIB?
Of the 13 reports, 1 (7.7%) resulted in death, 1 (7.7%) required hospitalization.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REVUMENIB. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does REVUMENIB Cause?
Off label use (57)
Platelet count decreased (50)
Nausea (49)
Product dose omission issue (40)
Death (38)
Vomiting (26)
Fatigue (24)
Pyrexia (22)
Differentiation syndrome (16)
Haemoglobin decreased (16)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which REVUMENIB Alternatives Have Lower Product use issue Risk?
REVUMENIB vs REYATAZ
REVUMENIB vs REZAFUNGIN
REVUMENIB vs RIBASPHERE
REVUMENIB vs RIBAVIRIN
REVUMENIB vs RIBOCICLIB